The Penn Center for Head and Neck Cancer is a multidisciplinary collaboration between Penn Ear Nose and Throat (ENT) and other specialties throughout the Abramson Cancer Center. This means that all of the specialists and clinicians on your team are in one place, and are dedicated to collaboration for the best comprehensive evaluation, diagnosis and care.
Cancers of the head and neck treated here include:
Established in 1991, the Penn Center for Head and Neck Cancer continues to serve as one of the largest cancer programs on the East Coast. The Center's mission is to focus on innovation and the delivery of compassionate head and neck cancer patient care.
Gregory S. Weinstein, MD, professor of otorhinolaryngology — head and neck surgery and Bert W. O'Malley, Jr., MD, chair of Penn's department of otorhinolaryngology — head and neck Surgery are co-directors for the Penn Center for Head and Neck Cancer. Together, they pioneered the creation of TransOral Robotic Surgery (TORS), the world's first group of minimally-invasive robotic surgery techniques that enable Penn surgeons to remove benign and malignant tumors of the mouth and throat.
The Ear, Nose and Throat program is nationally recognized by the U.S. News & World Report as one of the top 5 (#4) programs in the country.
Penn’s Center for Head and Neck Cancer offers the latest advancements in surgical and non-surgical approaches to treat cancer of the head and neck.
Penn oncologists provide expert evaluation, diagnosis and treatment for benign and malignant tumors of the head and neck.
Physicians at Penn's Head and Neck Cancer Center are available to answer questions patients may have about their cancer diagnosis and treatment.
Congratulations to the 184 Penn physicians listed below who were included in Philadelphia Magazine's Top Doctors 2016.
Penn Medicine is one of the world’s leading academic medical centers.
A clinical trial is a research study involving patient volunteers that are conducted to find safe and effective treatments for a variety of health conditions.